Stockreport

Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants [Yahoo! Finance]

Structure Therapeutics Inc. - American Depositary Shares  (GPCR) 
PDF SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral smal [Read more]